Product NDC: | 25021-134 |
Proprietary Name: | Ampicillin |
Non Proprietary Name: | ampicillin sodium |
Active Ingredient(s): | 250 mg/1 & nbsp; ampicillin sodium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-134 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA063145 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101001 |
Package NDC: | 25021-134-10 |
Package Description: | 10 INJECTION, POWDER, FOR SOLUTION in 1 CARTON (25021-134-10) |
NDC Code | 25021-134-10 |
Proprietary Name | Ampicillin |
Package Description | 10 INJECTION, POWDER, FOR SOLUTION in 1 CARTON (25021-134-10) |
Product NDC | 25021-134 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ampicillin sodium |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20101001 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | AMPICILLIN SODIUM |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Penicillin-class Antibacterial [EPC],Penicillins [Chemical/Ingredient] |